Brain News You Can Use | February 2018

Our Top Picks That Caught Our Eye Recently:

A Good Age: Bring Moments of Joy to Alzheimer’s Disease | The family of Michael Middleton of Hingham, who died in 2011 at age 77 from Alzheimer’s disease, has started a Memory Cafe at the South Shore Conservatory of Music in Hingham to help other families. Middleton loved music and the arts to the end of his life. (Source: The Patriot Ledger | Sue Scheible).

Brain ‘Pacemaker’ for Alzheimer’s Shows Promise In Slowing Decline | Implanting a pacemaker-like device in the brains of people with Alzheimer’s disease could help slow the decline in decision-making and problem-solving skills that’s typically seen in these patients, a new study suggests. (Source: LiveScience | Rachael Rettner).

FDA Sets the Stage for Earlier-Stage Alzheimer’s Treatments | The FDA has proposed new guidelines, which are aimed at lowering the clinical study goals of Alzheimer’s disease drugs for treating earlier-stage patients who have not yet displayed functional disability or clinical abnormality. (Source: Nasdaq | Zacks Equity Research).

Go Figure: Why Olympic Figure Skaters Don’t Fall Flat on Their Faces | Watching a fellow human jump into the air, spin three times and land on a thin piece of steel—all the while balancing on slippery ice—is an awe-inspiring experience. (Source: Scientific American | Yasemin Saplakoglu).

How Many Steps Should You Walk Daily for Brain Health | Most people think that memory problems and cognitive impairment are just a couple of the things we can look forward to as we age. But a growing body of research shows that a healthy lifestyle can help protect us from the brain effects of aging. (Source: Care2 | Michelle Schoffro Cook).

Pfizer Ends Its Neuroscience Program—What Does it Mean For Alzheimer’s? | Pfizer announced it is closing its neuroscience division. In a statement, the company said it made the decision in order to “focus on those areas where our pipeline, and our scientific expertise, is strongest.” (Source: Huffington Post | Howard Fillit, MD, Contributor).